In this study, we evaluated the immune response during the acute ZIKV infection by 57 analysis the serum levels of cytokines, chemokines and growth factors from an adult 58 cohort from Manaus, Brazil of 54 ZIKV-infected cases and 100 controls over five time 59 points during symptomatic ZIKV infection. We present the time course of cytokine 60 response in relation to viremia and identify a chemokine that may serve as a biomarker 61 of acute ZIKV infection, providing new insights into ZIKV neuropathogenesis. 62 63
Methods

64
Study Population and Design 65
We used a non-probabilistic convenience sampling and a cross-sectional experimental 66 design, together with robust statistical analysis and data mining, for the evaluation of 67 the immunological biomarker profile during acute ZIKV infection. In the first semester 68 of 2016, a total of 54 suspected ZIKV-infected cases (29 non-pregnant females and 25 69 males, all adults) were recruited at Hospital Adventista de Manaus, Amazonas state, 70
Brazil. All patients presented a maculopapular rash, with or without fever, and at least 71 one of the following symptoms: pruritus, arthralgia, joint swelling or conjunctival 72 hyperemia, within five days after the symptoms onset. 
Microbeads assay for serum biomarkers 95
High-performance microbeads 27-plex assay (Bio-Rad, Hercules, CA, USA) was 96 employed for detection and quantification of multiple targets, including: CXCL8 (IL-8); 97 CXCL10 (IP-10); CCL11 (Eotaxin); CCL3 (MIP-1α); CCL4 (MIP-1β); CCL2 (MCP-98 1); CCL5 (RANTES); IL-1β, IL-6, TNF-α; IL-12; IFN-γ, IL-17; IL-1Ra (IL-1 receptor 99 antagonist); IL-2; IL-4; IL-5; IL-7; IL-9; IL-10; IL-13; IL-15; FGF-basic; PDGF; 100 VEGF; G-CSF and GM-CSF. Samples were tested according to the manufacturer's 101 instructions on a Bio-Plax 200 instrument (Bio-Rad). The serum levels of IL-2, IL-7, 102 and IL-15 were below the detection limits in several samples and were excluded of 103 further analysis. The results were expressed as pg/mL. 104 105
Statistical analysis and Data mining 106
Statistical analyses were initially performed using GraphPad Prism (GraphPad Software 107 6.0, San Diego, CA, USA). Outliers within each measurement group were identified by 108 the ROUT Method (Q=1%) and removed. Cleaned data was then used for the evaluation 109 The dynamics of viremia, chemokines, cytokines and growth factors were evaluated 117 using the median value of each analyte. Comparative analysis of the biomarkers was 118 carried out by Kruskal-Wallis followed by Dunn's post-test. For all tests, significant 119 differences were considered at two-tailed p<0.05. 120
Data management strategies were applied to identify general and time-specific profiles. 121
Biomarker signature analysis was carried out as previously described [13] . Radar charts 122 were assembled to compile the biomarker signature of NI controls and ZIKV-infected 123 cases applying the 75 th percentile as threshold. Venn diagram scrutiny was carried out to 124 identify attributes, along with the timeline of the symptoms onset The 54 Brazilian Zika cases, 29 non-pregnant females (median age 38 years, IQR 27.5 -140 46.5) and 25 males (median age 37 years, IQR 30 -50), were enrolled between the first 141 and the fifth day after the symptoms onset. A group of 100 non-infected control subjects 142 who were residents of Manaus, Amazonas, Brazil were also included (46 females 143 (median age 28 years, IQR 23 -36) and 54 males (median age 29.5 years, IQR 23 -144 36)). The median viremia expressed as 1/Ct*100 was 2.9 (min=2.7; max=4.2; IQR: 2.8 145 -3.0). The frequency of specific ZIKV symptoms was similar between men and woman 146 with the only exception that men had increase frequency of fever compared to woman 147 (100% versus 67%, p=0.005) ( Viremia and biomarkers were assessed at different time-points (Day 1 post-infection 217 denoted as D1 etc.) D1 (n=11); D2 (n=13); D3 (n=10); D4 (n=09) and D5 (n=05). A 218 bimodal distribution was observed, with two viremia peaks at D2 and D4, reaching the 219 lowest levels at D5 (Fig 3, gray panel) . Dynamics of CCL5, TNF-α, IFN-γ, IL-17 and 220 G-CSF were closely related to viremia ( Fig 3A) . A similar bimodal distribution was 221 observed for IL-1β and IL-13 ( Fig 3B) . The highest levels of CXCL8 and CCL2 were 222 observed at D1 and D2 ( Fig 3C) . An inverse correlation was observed for IL-12, IL-10 223 and VEGF (Fig 3D) , where the highest levels coincide with the lowest viremias. The 224 levels of CCL3, CXCL10, IL-6 and FGF-basic display a distinct pattern, with the lowest 225 levels observed at D3, coinciding with the first drop of viremia ( Fig 3E) . A valley at D4 226 followed by an increase at D5 was observed for CCL11, CCL4, IL-1Ra, and IL-4 ( Fig  227   3F ), and unique patterns were observed for IL-5, IL-9, PDGF, and GM-CSF ( Fig 3G) . 
ZIKV infection elicited a set of general and timeline-specific biomarkers 270
The biomarker levels were used to build a signature (Fig 5, left panels) as described in 271 the methods section. A significant difference in the overall profile was observed in 272 ZIKV-infected cases (Fig 5, top-left panel) . Furthermore, the radar chart revealed that 273 19/24 (79%) biomarkers were highly induced by ZIKV infection (Fig 5, bottom-left  274 panel). Almost all biomarkers analyzed were found in levels above the global median in 275 more than 75% of the infected patients. 276
Venn diagram analysis showed that four chemokines (CCL4, CCL2, CCL5, CXCL10); 277 two cytokines (IL-6, IL-4) and two growth factors (PDGF, G-CSF) were significantly 278 induced in all time-points (Fig 5, right panel) . Of note, TNF-α appears as a single 279 biomarker at the intersection of the viremia peaks (D2 and D4). In contrast, IL-10 is the 280 only unregulated biomarker at viremia valleys (D3 and D5) while increased levels of 281 IL-12 appears at D5 (Fig 5, inserted table) . with the viremia peaks ( Fig 6) . 301 segregating them from controls. Additionally, a decision tree was built to identify the 318 biomarker most able to segregate patients. This approach confirmed the heatmap 319 observations indicating CXCL10 as the most relevant element, followed by IL-4 and 320 VEGF. The analysis showed a very high global accuracy (99.4%) with a leave-one-out-321 cross-validation of 96.8% (Fig 7) . The significance of these attributes (CXCL10, IL-4 322 and VEGF) was assessed by 3D-plots and the performance of the root attribute 323 High levels of CXCL10 have been previously described at acute and convalescent 457 phases, with more prominent expression at the latter [8]. Unfortunately, although our 458 data strongly suggest CXCL10 as a biomarker of ZIKV acute infection, we were unable 459 to perform a longitudinal analysis to verify its kinetics across different stages of the 460 disease, to further confirm whether the concentrations of this chemokine would be down 461 or up-regulated. In addition, CXCL10 elevation is also observed in pre-eclampsia and 462 hypertension found in pregnancy resulting in a range of fetal injuries, including 463 intrauterine growth retardation and neurological damage induced by hypoxia [45, 46] . 464
Thus, it is reasonable to suggest that ZIKV-induced inflammation may increase fetal 465 injuries. 466 CXCL10 may also be an important therapeutic target [40] . For example, CXCL10 467 neutralization by specific antibodies or genetic deletion in CXCL10-/-mice protected 468 against cerebral malaria infection and inflammation [47] . Passive transfer of anti-469 CXCL10 antibodies reduced inflammatory leukocyte recruitment across the blood brain 470 barrier. Furthermore, statin medications commonly used for cholesterol control have 471 been shown to decrease CXCL10 and to be effective in CXCL10 mediated Crohn's 472 disease [48] . 473
Finally, we describe the relationship between the timing of viremia and cytokine 474 elevations. The acute phase of ZIKV infection lasts around five days [49] . This study 475
